Fiscal.ai posted a chart comparing Lilly and Novo Nordisk and says Lilly is pulling ahead in the obesity drug market. Only the chart is shared, with no other detail.
Recap by typeshit. Post by Fiscal.ai on X.
ABC News' chief medical correspondent walks through the latest Novo Nordisk GLP-1 medication and what sets it apart from drugs already on the market.
Investseekers shares notes on the upcoming French rollout of the Wegovy pill and where Novo Nordisk might launch it next in Europe.
A short social clip runs through the daily checklist of a GLP-1 routine: injections, water, protein and keeping tabs on progress.
Kumar says month one is less about big drops on the scale and more about setting up habits that help the medication work over time.
The pharmacy boards group, per InsideHealthPolicy, ties reported deaths linked to retatrutide to weak enforcement against gray-market peptide sellers.
2:12
A short explainer on the experimental injection people call Reta, covering why it went viral and what is known so far about its safety.
Loading…